Vinay Rathore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Vinay Rathore has a total of 236 co-authors. Here are the top co-authors by number of shared publications:
- Amer M. Johri
Division of Cardiology, Department of Medicine, Queen’s University, Kingston, Canada
9 shared publications - Jasjit S. Suri
Department of ECE, Idaho State University, Pocatello, ID 83209, USA
9 shared publications - Luca Saba
Department of Radiology, Azienda Ospedaliero-Universitaria (A.O.U.) di Cagliari, 09124 Cagliari, Italy
9 shared publications - Narendra Nath Khanna
Department of Cardiology, Indraprastha Apollo Hospitals, New Delhi, India
9 shared publications - Mannudeep K. Kalra
Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA
8 shared publications - Martin Miner
Men's Health Center, Miriam Hospital, Providence, RI, USA; Departments of Medicine and Urology, Warren Alpert School of Medicine, Brown University, Providence, RI, USA
8 shared publications
Latest Publications
- 16 October 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Randomized Trial Comparing Minocycline-EDTA-Ethanol Lock to Standard-of-Care Antibiotic Lock for Management of Central Line–Associated Bloodstream Infection
Background: Central line–associated bloodstream infections (CLABSI) cause substantial morbidity and mortality. Management often requires removing the infected central venous catheter (CVC) and inserting a new one. Effective catheter-salvage strategies are needed. Methods: An international, multicenter, prospective, randomized superiority trial at 34 centers in the United States, Puerto Rico, and India enrolled patients aged ≥12 years with a long-term central venous catheter (CVC) in place for ≥5 days and CLABSI. Participants were randomized 1:1 to receive systemic antibiotics plus minocycline-EDTA-ethanol lock therapy (MLT) or standard-of-care antibiotic lock therapy (SOC-ALT) for 7 to 14 days. The primary endpoint was median time to catheter failure, defined as clinical failure (death, infection-related catheter removal, worsening symptoms) or microbial failure (persistent/recurrent infection or new deep-seated infection attributable to the index CLABSI). Results: From 2018-2024, 241 patients were randomized; 228 received lock therapy. Catheter retention was higher with MLT than SOC-ALT (57% vs 38%; P = 0.0025). Median time to catheter failure was longer with MLT in both intention-to-treat (not estimable vs 33 days, HR 0.53, P = 0.0006) and modified intention-to-treat populations (not estimable vs 35 days, HR 0.50, P = 0.0005). Clinical catheter failure (13% vs 28%; P = 0.006) and microbiological failure (5% vs 15%; P = 0.012) were lower with MLT. Adverse events, serious adverse events, and mortality were similar between groups, with no drug-related serious adverse events. Conclusions: MLT was superior to SOC-ALT in salvaging long-term CVCs in CLABSI and was well tolerated, addressing an unmet need in CLABSI management.
- 16 October 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Randomized Trial Comparing Minocycline-EDTA-Ethanol Lock to Standard-of-Care Antibiotic Lock for Management of Central Line–Associated Bloodstream Infection
Background: Central line–associated bloodstream infections (CLABSI) cause substantial morbidity and mortality. Management often requires removing the infected central venous catheter (CVC) and inserting a new one. Effective catheter-salvage strategies are needed. Methods: An international, multicenter, prospective, randomized superiority trial at 34 centers in the United States, Puerto Rico, and India enrolled patients aged ≥12 years with a long-term central venous catheter (CVC) in place for ≥5 days and CLABSI. Participants were randomized 1:1 to receive systemic antibiotics plus minocycline-EDTA-ethanol lock therapy (MLT) or standard-of-care antibiotic lock therapy (SOC-ALT) for 7 to 14 days. The primary endpoint was median time to catheter failure, defined as clinical failure (death, infection-related catheter removal, worsening symptoms) or microbial failure (persistent/recurrent infection or new deep-seated infection attributable to the index CLABSI). Results: From 2018-2024, 241 patients were randomized; 228 received lock therapy. Catheter retention was higher with MLT than SOC-ALT (57% vs 38%; P = 0.0025). Median time to catheter failure was longer with MLT in both intention-to-treat (not estimable vs 33 days, HR 0.53, P = 0.0006) and modified intention-to-treat populations (not estimable vs 35 days, HR 0.50, P = 0.0005). Clinical catheter failure (13% vs 28%; P = 0.006) and microbiological failure (5% vs 15%; P = 0.012) were lower with MLT. Adverse events, serious adverse events, and mortality were similar between groups, with no drug-related serious adverse events. Conclusions: MLT was superior to SOC-ALT in salvaging long-term CVCs in CLABSI and was well tolerated, addressing an unmet need in CLABSI management.
- 7 September 2026
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
Percutaneous peritoneal dialysis catheter making its way to the prevertebral space: A rare occurrence
Percutaneous peritoneal dialysis (PD) catheter insertion is widely performed by nephrologists and is generally safe; however, a lack of direct visualization may predispose to mechanical complications, including catheter malposition. We report a rare case of PD catheter migration into the retroperitoneal prevertebral space. A 33-year-old woman with chronic kidney disease stage 5 secondary to chronic glomerulonephritis underwent ultrasound-guided percutaneous Tenckhoff catheter insertion for initiation of continuous ambulatory PD. Although inflow was adequate, persistent outflow dysfunction prompted further evaluation. Imaging revealed that the catheter had traversed the posterior peritoneal wall and entered the prevertebral space anterior to the L5 vertebra. Laparoscopy confirmed the finding, and the catheter was successfully repositioned into the pelvis with closure of the peritoneal defect. The patient subsequently initiated PD with satisfactory catheter function. This case highlights an extremely rare catheter malposition and underscores the importance of early imaging and multidisciplinary management to salvage catheter function.
- 7 September 2026
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
Percutaneous peritoneal dialysis catheter making its way to the prevertebral space: A rare occurrence
Percutaneous peritoneal dialysis (PD) catheter insertion is widely performed by nephrologists and is generally safe; however, a lack of direct visualization may predispose to mechanical complications, including catheter malposition. We report a rare case of PD catheter migration into the retroperitoneal prevertebral space. A 33-year-old woman with chronic kidney disease stage 5 secondary to chronic glomerulonephritis underwent ultrasound-guided percutaneous Tenckhoff catheter insertion for initiation of continuous ambulatory PD. Although inflow was adequate, persistent outflow dysfunction prompted further evaluation. Imaging revealed that the catheter had traversed the posterior peritoneal wall and entered the prevertebral space anterior to the L5 vertebra. Laparoscopy confirmed the finding, and the catheter was successfully repositioned into the pelvis with closure of the peritoneal defect. The patient subsequently initiated PD with satisfactory catheter function. This case highlights an extremely rare catheter malposition and underscores the importance of early imaging and multidisciplinary management to salvage catheter function.
- Open Access
- 11 August 2026
- Published by Scientific Scholar in Indian Journal of Nephrology
- p. 1-8
Prevalence, Characteristics, and Associated Factors of Suspected Chronic Kidney Disease of Unknown Etiology in Supebeda Village of Chhattisgarh
Background: Supebeda, a small village in Chhattisgarh, has reported an alarmingly high number of chronic kidney disease (CKD) cases. The prevalence, epidemiology, and associated factors of suspected CKD in this village have not been studied methodologically. Materials and Methods: This cross-sectional study was carried out in Supebeda during a health camp organized from 1st May to 5th May 2023. A door-to-door health survey was organized. 163 (20%) participants selected by simple random sampling out of 813 villagers were screened for suspected CKD by measuring serum creatinine and urine protein-creatinine ratio (UPCR). Demographic, clinical, and laboratory variables were recorded. Further, ten community drinking water samples were analyzed for select potentially toxic chemical species. Results: The prevalence of suspected CKD, defined as eGFR 0.15 g/g). Thirty-eight participants (23.3%) with eGFR p = 0.004, OR 1.05, CI 1.01–1.08) and gudakhu use ( p = 0.012, OR 3.73, CI 1.33-10.40) were predictors of suspected CKDu. Out of ten drinking water samples, lithium and chromium were above the permissible limits in nine, while levels of fluoride and arsenic were above the maximum permissible limit in four and two samples, respectively. Conclusion: The study highlights a high prevalence of reduced GFR in the villagers, most of whom were not associated with traditional risk factors. However, these data represent a single-time assessment, and chronicity was not confirmed. So, the results only reflect abnormal kidney function compatible with CKD and CKDu.
- 11 August 2026
- Published by Scientific Scholar in Indian Journal of Nephrology
- p. 1-8
Open AccessPrevalence, Characteristics, and Associated Factors of Suspected Chronic Kidney Disease of Unknown Etiology in Supebeda Village of Chhattisgarh
Background: Supebeda, a small village in Chhattisgarh, has reported an alarmingly high number of chronic kidney disease (CKD) cases. The prevalence, epidemiology, and associated factors of suspected CKD in this village have not been studied methodologically. Materials and Methods: This cross-sectional study was carried out in Supebeda during a health camp organized from 1st May to 5th May 2023. A door-to-door health survey was organized. 163 (20%) participants selected by simple random sampling out of 813 villagers were screened for suspected CKD by measuring serum creatinine and urine protein-creatinine ratio (UPCR). Demographic, clinical, and laboratory variables were recorded. Further, ten community drinking water samples were analyzed for select potentially toxic chemical species. Results: The prevalence of suspected CKD, defined as eGFR 0.15 g/g). Thirty-eight participants (23.3%) with eGFR p = 0.004, OR 1.05, CI 1.01–1.08) and gudakhu use ( p = 0.012, OR 3.73, CI 1.33-10.40) were predictors of suspected CKDu. Out of ten drinking water samples, lithium and chromium were above the permissible limits in nine, while levels of fluoride and arsenic were above the maximum permissible limit in four and two samples, respectively. Conclusion: The study highlights a high prevalence of reduced GFR in the villagers, most of whom were not associated with traditional risk factors. However, these data represent a single-time assessment, and chronicity was not confirmed. So, the results only reflect abnormal kidney function compatible with CKD and CKDu.
- Open Access
- 23 June 2026
- Published by Elsevier in Kidney International Case Reports
- Vol. 1 (3)
Atypical IgAN Unmasked by Immune Reconstitution Inflammatory Syndrome in a Patient With HIV
- 23 June 2026
- Published by Elsevier in Kidney International Case Reports
- Vol. 1 (3)
Open AccessAtypical IgAN Unmasked by Immune Reconstitution Inflammatory Syndrome in a Patient With HIV
- 17 May 2026
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 41 (3) , e70133
Navigating Therapeutic Plasma Exchange in Critically Ill Children: A Retrospective Review of Indications, Timing, Outcomes, and Complications in a Developing Nation PICU
To retrospectively review the indications, timing, outcomes, and complications of membrane‐based therapeutic plasma exchange (mTPE) in critically ill children at a single‐center pediatric intensive care unit (PICU). Retrospective observational study. A tertiary‐care PICU at All‐India Institute of Medical Sciences (AIIMS), Raipur. A total of 106 patients aged 1 month to 18 years who underwent mTPE between January 2022 and December 2024. Patients had a median age of 144 months (IQR: 13–216). Renal and hepatic diseases were the most common indications. Overall, 61.3% of patients recovered and were discharged. Complications (inclusive of minor and line‐related events) were observed in 35.8% of patients. Logistic regression analysis identified fluid‐refractory shock at admission ( p < 0.001), elevated Pediatric Risk of Mortality (PRISM‐3) scores ( p = 0.007), and concurrent continuous renal replacement therapy (CRRT) ( p = 0.016) as statistically significant predictors of mortality. In the subgroup of patients with liver disease, time to mTPE initiation was an independent, significant predictor of mortality ( p = 0.013). Membrane‐based therapeutic plasma exchange is a safe and feasible adjunct therapy in critically ill children. While mTPE is most effective for conditions classified as American Society for Apheresis (ASFA) category I, its outcomes are highly variable and are significantly influenced by the underlying condition and the timing of the intervention, particularly for acute liver failure.
- 17 May 2026
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 41 (3) , e70133
Navigating Therapeutic Plasma Exchange in Critically Ill Children: A Retrospective Review of Indications, Timing, Outcomes, and Complications in a Developing Nation PICU
To retrospectively review the indications, timing, outcomes, and complications of membrane‐based therapeutic plasma exchange (mTPE) in critically ill children at a single‐center pediatric intensive care unit (PICU). Retrospective observational study. A tertiary‐care PICU at All‐India Institute of Medical Sciences (AIIMS), Raipur. A total of 106 patients aged 1 month to 18 years who underwent mTPE between January 2022 and December 2024. Patients had a median age of 144 months (IQR: 13–216). Renal and hepatic diseases were the most common indications. Overall, 61.3% of patients recovered and were discharged. Complications (inclusive of minor and line‐related events) were observed in 35.8% of patients. Logistic regression analysis identified fluid‐refractory shock at admission ( p < 0.001), elevated Pediatric Risk of Mortality (PRISM‐3) scores ( p = 0.007), and concurrent continuous renal replacement therapy (CRRT) ( p = 0.016) as statistically significant predictors of mortality. In the subgroup of patients with liver disease, time to mTPE initiation was an independent, significant predictor of mortality ( p = 0.013). Membrane‐based therapeutic plasma exchange is a safe and feasible adjunct therapy in critically ill children. While mTPE is most effective for conditions classified as American Society for Apheresis (ASFA) category I, its outcomes are highly variable and are significantly influenced by the underlying condition and the timing of the intervention, particularly for acute liver failure.
- Open Access
- 28 April 2026
- Published by Springer Nature in Cost Effectiveness and Resource Allocation
- Vol. 24 (1)
Financial strain beyond coverage: assessing out-of-pocket costs for dialysis care in chronic kidney disease at a tertiary care centre in Central India
The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY) was launched in 2018 to reduce financial risk arising out of catastrophic health expenditure.
- 28 April 2026
- Published by Springer Nature in Cost Effectiveness and Resource Allocation
- Vol. 24 (1)
Open AccessFinancial strain beyond coverage: assessing out-of-pocket costs for dialysis care in chronic kidney disease at a tertiary care centre in Central India
The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY) was launched in 2018 to reduce financial risk arising out of catastrophic health expenditure.
- Open Access
- 13 March 2026
- Published by Elsevier in Kidney International Case Reports
- Vol. 1 (1)
A Rare Coinfection of Leptospira and Hepatitis A Presenting as Immune Complex-Mediated Glomerulonephritis
- 13 March 2026
- Published by Elsevier in Kidney International Case Reports
- Vol. 1 (1)
Open AccessA Rare Coinfection of Leptospira and Hepatitis A Presenting as Immune Complex-Mediated Glomerulonephritis
- Open Access
- 21 January 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
- Vol. 40 (1) , 158-161
Emphysematous pyelonephritis in a nonfunctional graft kidney: a case for early nephrectomy?
Yeshwanth Mohan Yelavarthy, Anish Kumar Saha, Vinay Rathore, Jyoti Aggarwal, Shubham Majumdar, Amit Sharma, Sunil Kumar Behera, Sandeep Desai, Rahul Bhatia. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0031
- 21 January 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
- Vol. 40 (1) , 158-161
Open AccessEmphysematous pyelonephritis in a nonfunctional graft kidney: a case for early nephrectomy?
Yeshwanth Mohan Yelavarthy, Anish Kumar Saha, Vinay Rathore, Jyoti Aggarwal, Shubham Majumdar, Amit Sharma, Sunil Kumar Behera, Sandeep Desai, Rahul Bhatia. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0031
- Open Access
- 7 January 2026
- Published by Scientific Scholar in Indian Journal of Nephrology
- Vol. 36, 481-486
Serum and Urine Heavy Metal and Fluoride Levels in Patients of Chronic Kidney Disease of Unknown Etiology of Central India: A Case-Control Study
Background: Although several potential risk factors for CKDu have been proposed, robust epidemiological evidence remains sparse. This study compares the levels of heavy metals and fluoride in serum and urine of patients with CKDu with the age-, sex-, and CKD stage-matched controls with CKD of known etiology. Materials and Methods: This study was conducted from August 2022 to July 2023 in a tertiary care hospital in Central India. Fifty patients with CKDu and age-, sex-, and CKD stage-matched controls with CKD of known etiology between 18 to 60 years were recruited. Socio-demographic data were recorded in a structured proforma. Spot serum and urine samples were analyzed for levels of Iron (Fe), Lead (Pb), Copper (Cu), Manganese (Mn), Nickel (Ni), Cadmium (Cd), and Chromium (Cr) using Atomic Absorption Spectrophotometry (AAS). Serum and urine fluoride were measured using the ion-selective electrode method. Results: Most participants were male (n=37, 74%) and >50 years (50.28±7.46 years). Among the patients, 54% (n=27) had CKD Stage V, 28% (n=14) had CKD Stage IV, and 18% (n=9) had CKD Stage III. There were no significant differences in serum or urine levels of any analyzed heavy metals between the two groups. Patients exhibited significantly higher serum fluoride compared to the control group [0.022 (0.012,0.035) mg/L vs. 0.009 (0.008,0.014) mg/dL, p < 0.001. Urine fluoride levels did not differ significantly between the two groups. Conclusion: Patients with CKDu have elevated serum levels of fluoride compared to patients with CKD due to other causes.
- 7 January 2026
- Published by Scientific Scholar in Indian Journal of Nephrology
- Vol. 36, 481-486
Open AccessSerum and Urine Heavy Metal and Fluoride Levels in Patients of Chronic Kidney Disease of Unknown Etiology of Central India: A Case-Control Study
Background: Although several potential risk factors for CKDu have been proposed, robust epidemiological evidence remains sparse. This study compares the levels of heavy metals and fluoride in serum and urine of patients with CKDu with the age-, sex-, and CKD stage-matched controls with CKD of known etiology. Materials and Methods: This study was conducted from August 2022 to July 2023 in a tertiary care hospital in Central India. Fifty patients with CKDu and age-, sex-, and CKD stage-matched controls with CKD of known etiology between 18 to 60 years were recruited. Socio-demographic data were recorded in a structured proforma. Spot serum and urine samples were analyzed for levels of Iron (Fe), Lead (Pb), Copper (Cu), Manganese (Mn), Nickel (Ni), Cadmium (Cd), and Chromium (Cr) using Atomic Absorption Spectrophotometry (AAS). Serum and urine fluoride were measured using the ion-selective electrode method. Results: Most participants were male (n=37, 74%) and >50 years (50.28±7.46 years). Among the patients, 54% (n=27) had CKD Stage V, 28% (n=14) had CKD Stage IV, and 18% (n=9) had CKD Stage III. There were no significant differences in serum or urine levels of any analyzed heavy metals between the two groups. Patients exhibited significantly higher serum fluoride compared to the control group [0.022 (0.012,0.035) mg/L vs. 0.009 (0.008,0.014) mg/dL, p < 0.001. Urine fluoride levels did not differ significantly between the two groups. Conclusion: Patients with CKDu have elevated serum levels of fluoride compared to patients with CKD due to other causes.
- Open Access
- 15 December 2025
- Published by Scientific Scholar in Indian Journal of Nephrology
- Vol. 36, 518-519
Unveiling a Novel Co-occurrence: CIDP and NELL-1 Membranous Nephropathy
Unveiling a Novel Co-occurrence: CIDP and NELL-1 Membranous Nephropathy
- 15 December 2025
- Published by Scientific Scholar in Indian Journal of Nephrology
- Vol. 36, 518-519
Open AccessUnveiling a Novel Co-occurrence: CIDP and NELL-1 Membranous Nephropathy
Unveiling a Novel Co-occurrence: CIDP and NELL-1 Membranous Nephropathy